BSECompany Update13h ago · 16 Oct 2026, 05:28 pm
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Tatva Chintan Pharma Chem Ltd · 543321
✦ AI Summary
Tatva Chintan Pharma Chem Ltd has announced a schedule of analyst/investor meeting under SEBI regulations, to be held on October 26, 2026, with Motilal Oswal Investment Advisors Limited. The meeting will be a virtual one-on-one meeting and will not involve the sharing of confidential or unpublished price-sensitive information.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
1ca380c2-4a6d-4d25-8dbd-c9f92eb0c27e.pdf
View document text
Date:16October2026 Ref.No.:TCPCL/SEC/2026-27/00052
TheGeneralManager, TheManager,
Corporaterelationshipdepartment, Listingdepartment,
BSELimited NationalStockExchangeofIndiaLimited
PhirozeJeejeebhoyTowers, ExchangePlaza,C-1,Block-G,
DalalStreet,Fort, Bandra-KurlaComplex,Bandra(E),
Mumbai-400001 Mumbai-400051
ScripCode:543321 ScripSymbol:TATVA
Subject:IntimationofScheduleofAnalyst(s)/FinancialInstitution(s)/Investor(s)Meeting
DearSir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended, we hereby submit schedule of Analyst(s)/Financial
Institution(s)/Investor(s)meetingthattheCompanywouldbeparticipating:
Date Analyst(s)/Financial Type Mode
Institution(s)/Investor(s)
26October2026 MotilalOswalInvestment OnetoOneMeeting VirtualMeeting
AdvisorsLimited
Pleasenotethattheaboveissubjecttochange,ifany.
The Company will be referring to publicly available information for discussions during interaction in
themeeting.
Noconfidential/unpublishedpricesensitiveinformation(UPSI)willbesharedduringthemeeting.
The above information shall be made available on the website of the Company at
www.tatvachintan.com.
Kindlytakeaboveintimationonyour recordandoblige.
Thankingyou,
Yoursfaithfully,
ForTatvaChintanPharmaChemLimited
IshwarNayi
CompanySecretaryandComplianceOfficer
M.No.:A37444